The CBLI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBLI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CBLI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CBLI Detailed Price Forecast - CNN Money||View CBLI Detailed Summary - Google Finance|
|View CBLI Detailed Summary - Yahoo! Finance||View CBLI Stock Research & Analysis - Zacks.com|
|View CBLI Trends & Analysis - Trade-Ideas||View CBLI Major Holders - Barrons|
|View CBLI Call Transcripts - NASDAQ||View CBLI Breaking News & Analysis - Seeking Alpha|
|View CBLI Annual Report - CompanySpotlight.com||View CBLI OTC Short Report - OTCShortReport.com|
|View CBLI Fundamentals - TradeKing||View CBLI SEC Filings - Bar Chart|
|View Historical Prices for CBLI - The WSJ||View Performance/Total Return for CBLI - Morningstar|
|View the Analyst Estimates for CBLI - MarketWatch||View the Earnings History for CBLI - CNBC|
|View the CBLI Earnings - StockMarketWatch||View CBLI Buy or Sell Recommendations - MacroAxis|
|View the CBLI Bullish Patterns - American Bulls||View CBLI Short Pain Metrics - ShortPainBot.com|
|View CBLI Stock Mentions - StockTwits||View CBLI Stock Mentions - PennyStockTweets|
|View CBLI Stock Mentions - Twitter||View CBLI Investment Forum News - Investor Hub|
|View CBLI Stock Mentions - Yahoo! Message Board||View CBLI Stock Mentions - Seeking Alpha|
|View Insider Transactions for CBLI - SECform4.com||View Insider Transactions for CBLI - Insider Cow|
|View CBLI Major Holdings Summary - CNBC||View Insider Disclosure for CBLI - OTC Markets|
|View Insider Transactions for CBLI - Yahoo! Finance||View Institutional Holdings for CBLI - NASDAQ|
|View CBLI Stock Insight & Charts - FinViz.com||View CBLI Investment Charts - StockCharts.com|
|View CBLI Stock Overview & Charts - BarChart||View CBLI User Generated Charts - Trading View|
Cleveland Biolabs Reports Second Quarter 2018 Financial Results And Development Progress
Posted on Tuesday August 14, 2018
BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2018. Cleveland BioLabs ...
Cleveland Biolabs Announces Formation and Financing of an Anti-Aging Joint Venture
Posted on Tuesday August 14, 2018
BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (CBLI) today reported formation of a 50-50 joint venture, named Genome Protection, Inc. (GPI), between the company and Everon BioSciences, Inc. (Everon), a leader in understanding and targeting cellular mechanisms of aging and age-related diseases. GPI's goal is to develop and commercialize drugs for anti-aging applications capable of prolonging human health and life-span. CBLI and Everon contributed relevant IP, technologies and expertise to enable GPI to effectively execute an ambitious research and development program aimed at clinical testing of entolimod and development of new products for anti-aging and other indications associated with genome damage.
Cleveland BioLabs Announces Delay in Analysis of Biocomparability Data Required for Regulatory Submission
Posted on Monday August 06, 2018
BUFFALO, NY / ACCESSWIRE / August 6, 2018 / Cleveland BioLabs, Inc. (CBLI) today reported that the company has received vendor notification of delays in analytical analyses of a formulation biocomparability study required for the Company's regulatory submissions. Because the review by the United States Food and Drug Administration (FDA) of the company's pre-Emergency Use Authorization application does not take place on strict timelines, entolimod's review status with the FDA is unaffected.
Ikea’s departure from Cary leads to impairment charge for mall owner
Posted on Friday June 22, 2018
In the wake of Ikea’s departure from Cary Towne Center, the mall’s owner is moving toward an impairment charge on its books, according to public filings from the company.